|
|
|
|
 |
SANTA CLARA--- Symyx to Acquire Synthematix to Further Extend Software Offerings; Expands Options for Pharmaceutical and Biotech Customers and Complements Current Symyx Software Suite |
| Companies mentioned in this article: |
|
Biotech |
|
| 2/23/2005 @ 11:44 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
Symyx Technologies, Inc. (Nasdaq:SMMX) today announced that it has signed a definitive agreement to acquire privately-held Synthematix, Inc., based in Research Triangle Park, North Carolina. Synthematix is a provider of organic synthesis reaction planning software systems for scientific knowledge management in chemistry research, with customers primarily in the pharmaceutical and biotechnology industries. This acquisition enables Symyx to broaden its software offerings with additional capabilities for pharmaceutical discovery and biotech research.
Under the terms of the agreement, Symyx will pay approximately $13 million in cash to acquire all outstanding shares of Synthematix based on Synthematix's current revenue outlook, plus an additional potential earn out of up to $4 million over a one year period based on achievement of incremental revenue targets. As part of the acquisition, Symyx will further issue approximately 27,500 options of its Common Stock for unvested Synthematix employee options that Symyx will assume at the closing. As of December 31, 2004, Synthematix had cash and cash equivalents of approximately $1 million. The acquisition of Synthematix has been approved by the boards of directors of both companies and is expected to close in April, 2005, subject to various standard closing conditions.
Steven Goldby, chairman and chief executive officer of Symyx, commented, "We see a growing interest from customers for knowledge management solutions which help scientists make better, faster and more efficient decisions. The acquisition of Synthematix immediately extends our Renaissance(R) and IntelliChem software with specific capabilities for pharmaceutical discovery and biotech research, enabling customers to utilize one integrated solution spanning both their discovery and development research activities."
"By joining Symyx, Synthematix will take its success to the next level with a world-class organization that strengthens our commercial capabilities and deepens our technology excellence," said Clay B. Thorp, chairman of Synthematix and general partner of Catalysta Ventures, Synthematix's largest shareholder. "As a part of Symyx, we will bring together a much broader offering of products and technology for chemists from discovery through development," said Robin Smith, founder and chief executive officer of Synthematix.
Synthematix's products, consisting of the ARTHUR(TM) suite of software and informatics products as well as the Synthematix StructureSearch technology, complement the intelligent electronic lab notebook (iELN) offerings of IntelliChem, which Symyx purchased in November 2004, and its Renaissance high-throughput research and data warehousing software suite. The Company intends to maintain the Synthematix development group in its current location in North Carolina.
Symyx will combine Synthematix's software solutions with its suite of Renaissance and IntelliChem software to provide a unified set of tools for high-throughput and conventional research for chemistry-intensive organizations. The resulting integrated suite of applications will allow companies to replace paper laboratory notebooks with an electronic, searchable system, provide scientists with a robust, broad, and easy-to-use set of time-saving and enabling tools for planning and executing experiments, and provide the entire enterprise with real-time collaborative decision-support and analysis capabilities to help scientists, engineers and project managers make better decisions.
2005 Financial Outlook
For 2005, Symyx continues to expect total revenue of $108-$118 million, with an approximate 20% operating margin and diluted earnings per share of $0.40-$0.45 before charges and purchase adjustments arising from the acquisitions of IntelliChem, Inc. and Synthematix, Inc., including the revenue impact of the deferred maintenance write-down to fair value, and the amortization of intangible assets and other acquisition related expenses. On a GAAP basis, Symyx continues to expect 2005 diluted earnings per share of $0.35-$0.40, before adjusting for costs that will be incurred as a result of the requirement to expense employee stock options in the second half of 2005 and for charges and purchase adjustments arising from the acquisition of Synthematix, Inc.
About Symyx
Symyx develops and applies high-throughput experimentation methods, instrumentation and software to enable accelerated discovery of proprietary materials and processes in the chemical, petrochemical, pharmaceutical, electronics, consumer goods, and automotive industries. Symyx offers these proprietary technologies to customers seeking to transform their research productivity through research collaborations, Discovery Tools(R) sales, and the license of materials, intellectual property, and software. Information about Symyx, including reports and other information filed by the Company with the Securities and Exchange Commission, is available at www.symyx.com.
About Synthematix
Synthematix, Inc., based in Research Triangle Park, NC, provides fully integrated software solutions for chemists. Synthematix's proprietary technology allows chemists to conceive, design, calculate, record and report experiments. Synthematix's tools consist of the ARTHUR(TM) suite of informatics products, as well as Library Builder and StructureSearch technology. Synthematix customers include Sigma-Aldrich, Biogen Idec, Boston University's CMLD, Eisai Research Institute, Incyte Corporation, Inspire Pharmaceuticals, Kalexsyn, Memory Pharmaceuticals, Millennium Pharmaceuticals, OSI Pharmaceuticals and Plexxikon Corporation. Synthematix is supported by a broad base of investors, including Catalysta Ventures and Southern Capitol Ventures. |
| FreshMoney - California Mergers/Acquisitions/Funding |
|
|
| |
| Friday, August 29, 2008 |
 |
|
LIVERMORE--- Topcon Acquires Voxis, Inc., Scanner Technology Leader Posted 2:37 PM PST
SAN FRANCISCO--- ECO2 Plastics, Inc. Announces Bridge Financing up to $5 Million in Convertible Notes Posted 8:28 AM PST
|
| |
| Thursday, August 28, 2008 |
 |
|
LOS GATOS--- Procera Networks Secures $6 Million in Private Placement Financing Highlighted Links Posted 3:20 PM PST
SAN FRANCISCO--- Webcarzz , Inc. Secures $4 Million in Series A Funding Posted 2:58 PM PST
ALAMEDA--- Wind River to Acquire MIZI Research Posted 2:58 PM PST
MILPITAS--- Adaptec Agrees to Acquire Aristos Logic Posted 7:56 AM PST
SAN CLEMENTE--- LifeModeler, Inc. Successful with Multi-Million Dollar Private Offering Posted 7:45 AM PST
|
| |
| Wednesday, August 27, 2008 |
 |
|
TEMECULA--- Patient Safety Technologies Closes on $2.325 Million in Equity Financing Posted 3:52 PM PST
REDWOOD CITY--- Replay Solutions Receives $11 Million Investment From Sigma Partners, Hummer Winblad and Partech International Posted 3:50 PM PST
|
| |
| Tuesday, August 26, 2008 |
 |
|
SAN DIEGO--- Gen-Probe Announces $250 Million Stock Repurchase Plan Posted 3:50 PM PST
SAN MATEO--- Aptana Acquires Pydev, Leading Python IDE for Eclipse Posted 8:56 AM PST
SAN MATEO--- Brand.net Secures $10 Million in Series B Funding Posted 8:45 AM PST
PASADENA--- Arrowhead Announces $4.4 Million Investment by Current Shareholders Posted 8:37 AM PST
PALO ALTO--- HP Completes $13.9 Billion Acquisition of EDS Posted 8:32 AM PST
|
| |
| Monday, August 25, 2008 |
 |
|
SAN MATEO--- Conviva's Innovative LIVE Media Platform Attracts $20 Million Investment Posted 4:23 PM PST
IRVINE--- Broadcom to Acquire Digital TV Business from AMD Posted 6:22 AM PST
|
| |
| Friday, August 22, 2008 |
 |
|
REDWOOD CITY--- Trilliant Incorporated Secures $40 Million Equity Financing From MissionPoint Capital Partners and zouk ventures Posted 6:37 AM PST
SAN DIEGO--- Lpath Closes $6.7 Million Equity Financing Posted 6:36 AM PST
|
| |
| Thursday, August 21, 2008 |
 |
|
SAN DIEGO--- Red Door Interactive acquires Denver-based Breckenridge Communications Posted 4:07 PM PST
REDWOOD CITY--- Turn Secures $15 Million in Series C Financing Posted 10:06 AM PST
RANCHO CUCAMONGA--- EMRISE Corporation Completes Acquisition of Advanced Control Components Inc. Posted 8:39 AM PST
OCEANSIDE--- Nternational Stem Cell Corporation Arranges $ 3 Million Equity Financing Posted 8:02 AM PST
|
| |
| Wednesday, August 20, 2008 |
 |
|
SAN DIEGO--- Lilly Announces Completion of SGX Acquisition Posted 6:08 PM PST
|
| |
| Tuesday, August 19, 2008 |
 |
|
PALO ALTO--- HourTown Secures $1 Million in Funding Posted 7:53 AM PST
|
| |
| Monday, August 18, 2008 |
 |
|
SUNNYVALE--- Palo Alto Networks Raises $27 Million in Series C Financing Posted 7:30 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|